AZARGA

This brand name is authorized in Austria, Australia, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug AZARGA contains a combination of these active pharmaceutical ingredients (APIs):

1 Brinzolamide UNII 9451Z89515 - BRINZOLAMIDE

Brinzolamide is an inhibitor of carbonic anhydrase II (CA-II). Carbonic anhydrase (CA) is an enzyme found in many tissues of the body, including the eye. Inhibition of carbonic anhydrase in the ciliary processes of the eye decreases aqueous humour secretion resulting in a reduction in intraocular pressure (IOP) which is a major risk factor in the pathogenesis of optic nerve damage and glaucomatous visual field loss. Read about Brinzolamide

2 Timolol UNII P8Y54F701R - TIMOLOL MALEATE

Timolol is a non-selective beta-adrenergic receptor blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anaesthetic activity. Timolol reduces intra-ocular pressure, whether or not this is associated with glaucoma. Read about Timolol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01ED51	Timolol, combinations	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01ED Beta blocking agents
Discover more medicines within S01ED51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 3438Y, 5562R
Country: CA	Health Products and Food Branch	Identifier(s): 02331624
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00672188, 00672194, 05481004, 05749547, 05749553, 05885718, 05885724, 06116264, 06330253, 06330276, 07776910, 10931171, 11079246, 11667960, 11667977, 16002610, 16840417, 16939759
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 29335-08-10
Country: EE	Ravimiamet	Identifier(s): 1392207, 1392218
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 08482001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 027202, 027214
Country: FR	Base de données publique des médicaments	Identifier(s): 65711858
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 154543, 180517, 185461, 374301, 376211, 379797
Country: HK	Department of Health Drug Office	Identifier(s): 58563
Country: IE	Health Products Regulatory Authority	Identifier(s): 13112, 53502, 53551, 53565
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6792
Country: IT	Agenzia del Farmaco	Identifier(s): 038837011
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1005525, 1035363
Country: NG	Registered Drug Product Database	Identifier(s): B4-5549
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 88552
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 13770
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100201818
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64501001, W64501002
Country: SG	Health Sciences Authority	Identifier(s): 13802P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699504710106
Country: ZA	Health Products Regulatory Authority	Identifier(s): 44/15.4/0046